OncoVerse is a digital health platform which allows cancer patients’ care teams to collaborate and also allows clinicians across all disciplines to work together to establish the most effective treatment plan for their patients.
NetScientific chief François Martelet on the 'strong return' from sale of OncoVerse
Quick facts: Netscientific PLC
Price: 63 GBX
Market Cap: £9.4 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Netscientific PLC named herein, including the promotion by the Company of Netscientific PLC in any Content on the Site, the Company receives...FOR OUR FULL DISCLAIMER CLICK HERE